Derazantinib, CAS [[1234356-69-4]]

Produktübersicht

• Artikelname: Derazantinib, CAS [[1234356-69-4]]
• Artikelnummer: BYT-ORB1296116
• Hersteller Artikelnummer: orb1296116
• Alternativnummer: BYT-ORB1296116-1, BYT-ORB1296116-1, BYT-ORB1296116-10, BYT-ORB1296116-100, BYT-ORB1296116-200, BYT-ORB1296116-25, BYT-ORB1296116-5, BYT-ORB1296116-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: ARQ 087, ARQ087, ARQ-087, Derazantinib, inhibit, Inhibitor, Fibroblast growth factor receptor, FGFR, FGFR1, FGFR2, FGFR3

Produktbeschreibung

Derazantinib (ARQ-087) is an orally bioavailable, ATP-competitive inhibitor targeting fibroblast growth factor receptors (FGFRs) with low nanomolar potency. It is used in research to investigate FGFR-driven pathologies, demonstrating activity in both in vitro assays and in vivo tumor models.

Produkteigenschaften

• Molekulargewicht: 468.57
• Reinheit: 99.95% (May vary between batches)
• CAS Nummer: [1234356-69-4]
• Formel: C29H29FN4O
• Target-Kategorie: FGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.04 mM),DMSO:98 mg/mL (209.15 mM)